A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation
- 2 June 2020
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 60 (7), 1529-1535
- https://doi.org/10.1111/trf.15825
Abstract
BACKGROUND Cryopreservation of CD34+ hematopoietic stem cells (HSCs) is associated with variable loss of viability. Although postfreezing CD34+ cell viability can be assessed on the sampling tube (bag tail) directly connected to the main bag (mother bag), results often underestimate the actual viability observed when the mother bag is thawed and reinfused. We assessed a novel method to measure postfreezing CD34+ cell viability, based on small bag (minibag) samples; results were compared with those obtained on the corresponding mother bags and bag tails. STUDY DESIGN AND METHODS Sixty‐one apheresis procedures of 42 patients undergoing autologous HSC transplant were analyzed. Viable CD34+ cells were quantified with flow cytometry before controlled rate freezing (ICE‐CUBE14M system, SY‐LAB‐ IceCube, SIAD), after 10 days of storage (mini‐bag and bag tail), and before reinfusion (aliquot from a thawed mother bag). Results were compared using Studentʼs t test and Spearmanʼs rho correlation test. RESULTS The mean CD34+ cell viability before cryopreservation was 99.3% (confidence interval [CI], 98.94‐99.65%); the mean amount of CD34+ cells, white blood cells and neutrophils in the mother bag was 0.8 ± 1.1 × 109/L, 63.4 ± 23.5 × 109/L, and 25.7 ± 15.5 × 109/L, respectively. Mother bags postthawing CD34+ cell viability was 72.3% (CI, 67.74‐76.85%; p < 0.01 compared to prefreezing); no difference was observed with respect to minibags (73.7%; CI, 69.80‐77.59%; p = NS), whereas significantly lower values were found for bag tails (58.6%; CI, 54.19‐63.00%; p < 0.01 vs. both mini‐ and mother bags). CONCLUSION Compared to bag tails, minibags represent a more accurate tool to measure the CD34+ cell viability of the apheresis mother bag prior to reinfusion; in addition, minibags may could be of help for case‐by‐case calculation of the amount of apheresis to be infused to patients undergoing autologous HSC transplant.This publication has 20 references indexed in Scilit:
- Development and validation of a rapid, aldehyde dehydrogenase bright–based cord blood potency assayBlood, 2016
- Post-Thaw Viable CD45 + Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant DiseasesTransplantation and Cellular Therapy, 2015
- Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantationVox Sanguinis, 2015
- Effects of interruptions of controlled‐rate freezing on the viability of umbilical cord blood stem cellsTransfusion, 2014
- Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell productsCytotherapy, 2014
- Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomesTransfusion, 2014
- Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantationTransfusion and Apheresis Science, 2014
- The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipientsBone Marrow Transplantation, 2007
- Cryopreservation of hematopoietic stem cellsAmerican Journal of Hematology, 2007
- A technical bias: Differences in cooling rates prevent ampoules from being a reliable index of stem cell cryopreservation in large volumesCryobiology, 1986